Combination formoterol and inhaled steroid as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Cates, Christopher J ^a   Lasserson, Toby J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; COMBIN; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; SALBUTAMOL; TERBUTALINE; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; INHALER; INTERVENTION STUDY; LOW DRUG DOSE; MAINTENANCE THERAPY; META ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 55049137426     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007313     Document Type: Review

References (13)

1. Adams 2005 Adams NP, Bestall JC, Lasserson TJ, Jones PW, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: DOI: 10.1002/14651858.CD003135.pub3.]
2. BTS/SIGN 2008 British Thoracic Society. British Guidelines on Asthma Management. Thorax 2008; Vol. 63, issue Suppl 1.
3. Delea 2008 Delea TE, Hagiwara M, Stanford RH, Stempel DA. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma. Clinical Therapeutics 2008; Vol. 30, issue 3: 560-71.
4. FitzGerald 2004 FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004; Vol. 59, issue 7:550-6.
5. Greenstone 2005 Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, et al.Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005533]
6. Harrison 2004 Harrison T, Oborne J, Newton S, Tattersfield A. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; Vol. 363, issue 9405:271-5.
7. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
8. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] Available from:www.cochrane-handbook.org. The Cochrane Collaboration, 2008.
9. Lötvall 2004 Lötvall J. Combination therapy in asthma - fixed or variable dosing in different patients?. Current Medical Research and Opinion 2004; 20(11):1711-27.
10. Ni Chroinin 2005 Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, et al.Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database of Systematic Reviews 2005, Issue 4. [Art. No.: CD005535. DOI: 10.1002/14651858.CD005535]
11. Salpeter 2006 Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Annals of Internal Medicine 2006;144(14): 904-12.
12. Sovani 2008 Sovani MP, Whale CI, Oborne J, Cooper S, Mortimer K, Ekstr, et al.Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?. British Journal of General Practice 2008; Vol. 58:37-43.
13. Walters 2007 Walters EH, Gibson PG, Lasserson TJ, Walters JAE. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database of Systematic Reviews 2007, Issue 1. [Art. No.: CD001385. DOI: 10.1002/14651858.CD001385.pub2]